Glucagon-like peptide type 1 receptor agonistsIncretin effect and systemic effects of glucagon-like peptide type 1 and its agonists The incretin effect describes the phenomenon whereby oral glucose elicits higher (23 times) insulin secretory responses than does intravenous glucose.25 This is due to incretin hormones, such as GLP-1 or glucose-dependent insulinotropic polypeptide, which stimulate insulin secretion in response to food intake
Keep meal portions to 2 cups or less, and drink 810 glasses of water daily, as GLP-1 therapy can reduce thirst
One client told me her husband asked if she'd gotten botox, when really she'd just had her first beauty IV the day before
Springer Copyright 2017, Cham (CH (2017)
The general principle described in clinical teaching is to establish a baseline, recheck IGF-1 after the early weeks of any protocol, keep it within an age-appropriate reference range rather than pushing it into supraphysiologic territory, and monitor fasting glucose in at-risk patients